|
US2004096461A1
|
|
Chimeric multivalent polysaccharide conjugate vaccines
|
|
US7022098B2
|
|
Access disconnection systems and methods
|
|
US2003133829A1
|
|
Process for inactivating pathogens in a biological material
|
|
WO0243665A2
|
|
Ahf associated dispersion system and method for preparation
|
|
AU8067401A
|
|
Mini-adenoviral vector system for vaccination
|
|
AUPR363701A0
|
|
Method for the production of nuclear transfer embryos
|
|
AUPR247901A0
|
|
Activation of nuclear transfer embryos
|
|
AU2408700A
|
|
Method and apparatus for selectively removing xenoreactive antibodies from blood, serum or plasma
|
|
US6706690B2
|
|
Hemoactive compositions and methods for their manufacture and use
|
|
US5269946A
|
|
Systems and methods for removing undesired matter from blood cells
|
|
US4898584A
|
|
Implantable patient-activated fluid delivery device
|
|
US4898585A
|
|
Implantable patient-activated fluid delivery device with bolus injection port
|
|
US4898583A
|
|
Implantable patient-activated fluid delivery device and outlet valve therefor
|
|
US4840017A
|
|
Method for filling collapsible containers
|
|
US4803991A
|
|
Three electrode hydroquinone subcutaneous equilibrating tonometer
|
|
US4823833A
|
|
Fluid communication device
|
